Last reviewed · How we verify
Manuka honey in lozenge form
Manuka honey in lozenge form is a Small molecule drug developed by Radiation Therapy Oncology Group. It is currently in Phase 2 development.
At a glance
| Generic name | Manuka honey in lozenge form |
|---|---|
| Sponsor | Radiation Therapy Oncology Group |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Manuka honey in lozenge form CI brief — competitive landscape report
- Manuka honey in lozenge form updates RSS · CI watch RSS
- Radiation Therapy Oncology Group portfolio CI
Frequently asked questions about Manuka honey in lozenge form
What is Manuka honey in lozenge form?
Manuka honey in lozenge form is a Small molecule drug developed by Radiation Therapy Oncology Group.
Who makes Manuka honey in lozenge form?
Manuka honey in lozenge form is developed by Radiation Therapy Oncology Group (see full Radiation Therapy Oncology Group pipeline at /company/radiation-therapy-oncology-group).
What development phase is Manuka honey in lozenge form in?
Manuka honey in lozenge form is in Phase 2.